The FDA has issued an alert regarding a safety concern with certain Boston Scientific defibrillator leads used in implantable cardioverter defibrillators. The affected models include Endotak Reliance, ...

Cardiology is undergoing a year of rapid change, driven by innovations that are expanding diagnostic capabilities, advancing treatment options and personalizing care. From artificial intelligence and ...

The advantage over balloon angioplasty in this higher-risk subset was consistent with the results seen in single-layer ISR.

Surmodics, Inc. SRDX delivered adjusted earnings per share (EPS) of 6 cents in the third quarter of fiscal 2025 against the ...

"Driven by urgent unmet needs and scientific advances, the Alzheimer's Disease DMT market is poised for rapid growth as pharmaceutical companies shift their focus to multi-target therapies that ...

The demand for erectile dysfunction devices is largely fueled by the growing incidence of ED, especially among men with chronic health conditions lik ...

Detailed price information for Medpace Holdings Inc (MEDP-Q) from The Globe and Mail including charting and trades.

The Rare Therapies Launch Pad pilot aims to create a streamlined path to develop individualized treatments and get them approved.

Thirteen people were arrested in connection with a human trafficking bust carried out by Boston, state and federal ...

Boston City Councilor Ed Flynn is trying to declare the area around Mass and Cass a public health and humanitarian crisis.

Boston Scientific BSX has put up double-digit sales and profit growth figures every quarter for at least the last two years.